ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.00%
Dow Jones
38,778.10
0.00%
US Dollar vs MXN
18.32745
-1.12%
Brent Oil
83.675
-0.27%
Bitcoin
65,172.02
-1.98%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Genelux Corporation (GNLX)

  7. Genelux Corporation (GNLX) Noticias

GNLX

Genelux (GNLX)

Genelux Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GNLX
FechaHoraFuenteTítuloSímboloCompañía
14/06/202415:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:GNLXGenelux Corporation
14/06/202415:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GNLXGenelux Corporation
14/06/202415:10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GNLXGenelux Corporation
07/06/202420:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
04/06/202420:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
24/05/202416:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
24/05/202407:00GlobeNewswire Inc.Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsNASDAQ:GNLXGenelux Corporation
23/05/202415:01GlobeNewswire Inc.Genelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:GNLXGenelux Corporation
09/05/202415:25GlobeNewswire Inc.Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
09/05/202415:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
01/04/202406:00GlobeNewswire Inc.Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GNLXGenelux Corporation
13/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GNLXGenelux Corporation
02/02/202415:36Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GNLXGenelux Corporation
02/02/202415:06Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GNLXGenelux Corporation
15/12/202315:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
27/11/202306:00GlobeNewswire Inc.Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian CancerNASDAQ:GNLXGenelux Corporation
14/11/202316:50GlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
19/09/202316:37Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:GNLXGenelux Corporation
14/09/202306:00GlobeNewswire Inc.Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GNLXGenelux Corporation
13/09/202319:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
07/09/202315:01GlobeNewswire Inc.Genelux Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:GNLXGenelux Corporation
28/08/202306:00GlobeNewswire Inc.Genelux Corporation Announces New Chief Financial OfficerNASDAQ:GNLXGenelux Corporation
14/08/202306:00GlobeNewswire Inc.Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
02/08/202315:00GlobeNewswire Inc.Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2023NASDAQ:GNLXGenelux Corporation
20/07/202315:45GlobeNewswire Inc.Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New HiresNASDAQ:GNLXGenelux Corporation
29/06/202306:00GlobeNewswire Inc.Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLCNASDAQ:GNLXGenelux Corporation
29/06/202305:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:GNLXGenelux Corporation
22/06/202306:00GlobeNewswire Inc.Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023NASDAQ:GNLXGenelux Corporation
12/06/202306:00GlobeNewswire Inc.Genelux Corporation Announces $18 Million Private PlacementNASDAQ:GNLXGenelux Corporation
12/06/202305:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNLXGenelux Corporation
 Showing the most relevant articles for your search:NASDAQ:GNLX

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
CCOM
US500
US 500
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados